sorafenib has been researched along with mannose in 2 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (mannose) | Trials (mannose) | Recent Studies (post-2010) (mannose) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 9,698 | 41 | 2,248 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Hou, T; Wang, T; Yin, X; Zhang, J; Zhang, N | 1 |
Alés, E; Castillejos, MC; Cepeda-Franco, C; de la Cruz-Ojeda, P; Flores, JA; Gutiérrez-Valencia, A; Khiar, N; Mena-Barragán, T; Muntané, J; Navarro-Villarán, E; Negrete, M; Romero-Ben, E; Rosales-Barrios, C | 1 |
2 other study(ies) available for sorafenib and mannose
Article | Year |
---|---|
Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core-shell nanoparticles for enhanced tumor-localized chemoimmunotherapy.
Topics: Animals; Benzamides; Carcinoma, Hepatocellular; Cell Survival; Chitosan; Drug Carriers; Humans; Immunotherapy; Liver Neoplasms; Macrophages; Mannose; Mice; Microscopy, Confocal; Nanoparticles; Protein Kinase Inhibitors; RAW 264.7 Cells; Sorafenib; Tissue Distribution | 2019 |
PDA-Based Glyconanomicelles for Hepatocellular Carcinoma Cells Active Targeting Via Mannose and Asialoglycoprotein Receptors.
Topics: Antineoplastic Agents; Apoptosis; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Cell Proliferation; Endosomes; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Mannose; Mannose Receptor; Micelles; Nanoparticles; Polyacetylene Polymer; Sorafenib | 2021 |